THE INVESTOR'S GUIDE TO WARRANTS:
Capitalize on the Fastest Growing Sector of the
Stock Market, Second Edition (Hardcover)
by Andrew McHattie Rating: ISBN-10: 027303751X
Quick Links:
Back to Home Page Back to Warrant Sheets
Back to Expired Warrants
Address: 400 - 155 108th
Ave NE
Bellevue WA United States 98004
Phone: 416 360 6390
Web Site:
https://www.trilogy-international.com
Warrant Symbol - TRL.WT
Number Trading - 89621T 11 6
Expiration Date - February 7,
2022
Cusip - 89621T 11 6
Exercise Price - $11.50
Warrants called to trade news:
Trilogy Int'l loses $40.6M
(U.S.) from 2016 cont. ops
2017-03-27 08:11 MT -
News Release
On Feb. 7, 2017, Alignvest
Acquisition (AQX), a special
purpose acquisition corporation
listed on the Toronto Stock
Exchange, and Trilogy
International Partners LLC
completed a transaction in which
AQX invested $199.3-million in
Trilogy LLC. At the same time,
certain minority shareholders of
2degrees exchanged their
2degrees stock for AQX shares.
As a result of these
transactions, AQX acquired a
53-per-cent equity stake in
Trilogy LLC. AQX has been
renamed Trilogy International
Partners. Its common shares
trade on the Toronto Stock
Exchange under the ticker TRL
and its warrants trade on the
exchange under the ticker
TRL.WT.
Alignvest name change to Trilogy
International
2017-02-07 12:52 MT - Change
Name
The Toronto Stock Exchange
reports that Alignvest
Acquisition Corp. has completed
its qualifying acquisition of
Trilogy International Partners
LLC as well as an offering of
$81.4-million worth of unlisted
Class B shares for $10 per
share.
According to the TSX, as a
result of the acquisition, each
Class A share of Alignvest will
be automatically converted into
one share of the resulting
company, Trilogy International
Partners Inc., and each
Alignvest warrant will be
converted into one warrant of
Trilogy. The Trilogy securities
will begin trading at the open
on Feb. 9, 2017, and the
Alignvest securities will be
delisted on the same day. The
TSX reports that there will be
44,177,149 shares and 13,402,688
warrants of Trilogy issued and
outstanding, with 52,737,605
Trilogy shares reserved for
issuance. The Trilogy shares
will trade under the symbol TRL
and Cusip No. 89621T 10 8, while
the Trilogy warrants will trade
under the symbol TRL.WT and
Cusip No. 89621T 11 6.
According to the TSX, the
Trilogy warrants will be
exercisable at $11.50 per share
starting 30 days following the
closing of the qualifying
acquisition. The warrants will
expire at 5 p.m. on Feb. 7,
2022.
For more information, see
Alignvest's prospectus dated
Dec. 20, 2016, its notice of
special meeting of shareholders
and management information
circular dated Dec. 22, 2016,
and its amendment to the
circular dated Jan. 12, 2017.
All documents are available on
SEDAR.
© 2017 Canjex Publishing Ltd.
All rights reserved.
- Expiration Date: The last day the warrants can be exercised. If warrants aren't going to be exercised then they must be sold the day before the expiry date. The longer the time to expiry the more valuable the warrants.
- Leverage: A measure of how much you can increase your exposure to a share if you bought warrants instead of making a direct investment. It is the current share price divided by the current price of the warrant.
- Intrinsic Value: The difference between the exercise price and the actual trading price of the common stock. Once the common has gone over the exercise price, the warrants are "In the Money."
- Volatility: The higher the volatility rating, the higher the price of the warrant. Historical volatility is calculated by using the standard deviation of an underlying stock price over a specific period.
- Time Value: The difference between the current warrant price and its intrinsic value. Interpreted as the consideration paid for the advantage the warrant buyer has over the direct investor.
